Bone Biologics (BBLG) Research & Development (2016 - 2017)
Historic Research & Development for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to $345143.0.
- Bone Biologics' Research & Development fell 5051.05% to $345143.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $2.2 million, marking a year-over-year decrease of 7841.47%. This contributed to the annual value of $82044.0 for FY2021, which is 7591.7% down from last year.
- Latest data reveals that Bone Biologics reported Research & Development of $345143.0 as of Q4 2017, which was down 5051.05% from $234264.0 recorded in Q3 2017.
- Bone Biologics' 5-year Research & Development high stood at $4.7 million for Q1 2016, and its period low was $234264.0 during Q3 2017.